Rentschler Biopharma Experts contribute to Pharma´s Almanac Q2 Roundtable

June 16, 2021 Rentschler Biopharma Experts contribute to Pharma´s Almanac Q2 Roundtable

Wolfram Schulze, our Vice President Information Systems & Organization and Dr. Cora Kaiser, our Senior Director Corporate Communication, joined industry experts in the latest Pharma’s Almanac Roundtable.

Addressing evolving technologies at our company, Wolfram Schulze said, “The application of evolving technologies like artificial intelligence, machine learning and mixed reality is an important pillar of our digital agenda at Rentschler Biopharma. Hence, these are an integral part of our planning for strategic expansions and new services in the future. It is no secret that innovative technologies provide us and our clients a competitive edge in our sector by enhancing traditional services by digital means”.

Dr. Cora Kaiser elaborated on how we are aligning social media with our strategic goals by noting, “Raising awareness for our sector’s contribution in simplifying the complexities of drug development, in the face of the pandemic and beyond, has been my personal mission in communication and therefore guides our social media strategy. Ever since the pandemic triggered the shift to the home-office format, social media has become all the more important in bringing Rentschler Biopharma closer to the world”.

To read the entire articles, please follow this links:

  1. How have evolving technologies like artificial intelligence (AI) and machine learning (ML) changed how you conduct research, manufacturing, or business? More here.
  2. How is your organization using social media to extend your marketing efforts? More here.

Contact Person:
Rentschler Biopharma SE
Dr. Cora Kaiser
Senior Director Corporate Communication
communications@rentschler-biopharma.com